Huaxin Biomedical Science and Technology

Huaxin Biomedical is a China-based biotechnology company focused on the development and commercialization of high-quality recombinant protein drugs and monoclonal antibodies. The company leverages its proprietary high-efficiency protein expression and purification platforms to target significant unmet needs in ophthalmology, immunology, and oncology. Its lead programs include biosimilars and innovative biologics targeting VEGF for retinal diseases and TNF-alpha for autoimmune conditions. Huaxin Biomedical aims to provide affordable, high-efficacy therapeutic solutions to the global market through advanced biomanufacturing processes.